Dna X Debt-to-Equity Ratio Growth & History (SONM)

Dna X's debt-to-equity ratio was 0.00 for fiscal 2023.

View full Dna X company overview

Dna X annual debt-to-equity ratio history

Dna X annual debt-to-equity ratio

Fiscal yearPeriod endedDebt-to-equity ratioChangeGrowth
20232023-12-310.00−0.01−76.86%
20222022-12-310.01−0.00−7.49%
20212021-12-310.01−0.00−9.85%
20202020-12-310.01−0.39−96.81%
20192019-12-310.40−2.24−84.85%
20182018-12-312.63

Dna X debt-to-equity ratio trends

Over the last five fiscal years, Dna X's debt-to-equity ratio decreased from 2.63 to 0.00, a change of −2.63. The latest reported quarter, Q4 2023, shows 0.00.

About the metric

What the debt-to-equity ratio means

The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.

Calculation and source

How debt-to-equity is calculated

TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Dna X source filings ↗

Community posts

It’s quiet here.

No posts about SONM yet. Start the conversation.

Write the first post